Lv2
160 积分 2021-07-22 加入
Fibrosis: cross-organ biology and pathways to development of innovative drugs
6小时前
已完结
Publisher Correction: Fibrosis: cross-organ biology and pathways to development of innovative drugs
6小时前
已关闭
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
13天前
已完结
Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity
24天前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
2个月前
已完结
生物制剂在系统性红斑狼疮中应用的中国专家共识（2024版）
2个月前
已完结
Sequence modeling and design from molecular to genome scale with Evo
2个月前
已完结
Transmembrane domain–driven PD-1 dimers mediate T cell inhibition
3个月前
已完结
Cytokine storm and targeted therapy in hemophagocytic lymphohistiocytosis
4个月前
已完结
Murine Models of Secondary Cytokine Storm Syndromes
4个月前
已完结
皖公网安备34019202002308
